In the space of 100 days, the world of business dramatically changed. In discussions with my own board of directors as well as colleagues and confidants across the corporate world, I have noticed a distinctly different tone.regular deal-focused column
We are experiencing a reckoning after the prolonged low-interest environment that fuelled a near-universal asset bubble.The unwinding of this shared valuation delusion was a shock to few, although the suddenness caught many off guard. Unsurprisingly, balance sheet health has become the number one topic of discussion for directors right now, particularly at the smaller end.
The “pay to play” model is making a return, where shareholders either participate in a severely discounted round or face near wipeout.of a strong management team forced to raise $18 million by diluting any non-participants by a third, and at a price 85 per cent lower than the IPO of two years ago. The coming months will see a equivalent deals in private markets offered at even more dilutive valuations.
Awesome to have this sort of boardroom insight. Thanks 👏👏👏